Ajinomoto Co has executed a merger agreement to acquire all of the capital stock of Althea Technologies for approximately US$175m. Through this acquisition, Ajinomoto aims to strengthen its business foundation and expand in the rapidly growing advanced biomedical field. According to an official press release, the company 'aspires to achieve revenue of JPY 30bn by 2020'.